Nobel Biocare Services AG, a leading name in dental implant and restorative solutions, is headquartered in Switzerland (CH) and operates globally, with a strong presence in Europe, North America, and Asia. Founded in 1952, the company has pioneered advancements in dental technology, notably introducing the first commercially available dental implant. Nobel Biocare's core offerings include dental implants, prosthetics, and digital solutions, all designed to enhance patient outcomes and streamline dental procedures. Their innovative products, such as the NobelActive implant and the NobelClinician software, are distinguished by their precision and reliability. Recognised for their commitment to quality, Nobel Biocare has established a prominent market position, earning accolades for their contributions to the field of implant dentistry.
How does Nobel Biocare Services AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Nobel Biocare Services AG's score of 21 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Nobel Biocare Services AG, headquartered in Switzerland (CH), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges available for the company. As a result, it is unclear what specific initiatives or commitments Nobel Biocare has undertaken regarding carbon emissions reduction or climate action. The lack of data suggests that the company may still be in the early stages of developing its climate strategy or reporting framework. In the context of the industry, many organisations are increasingly adopting science-based targets and sustainability initiatives to mitigate their environmental impact. However, without specific commitments or data from Nobel Biocare, it is difficult to assess their position relative to industry standards.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Nobel Biocare Services AG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
